8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Type I interferon is required for T helper (Th) 2 induction by dendritic cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Type 2 inflammation is a defining feature of infection with parasitic worms (helminths), as well as being responsible for widespread suffering in allergies. However, the precise mechanisms involved in T helper (Th) 2 polarization by dendritic cells ( DCs) are currently unclear. We have identified a previously unrecognized role for type I IFN ( IFN‐I) in enabling this process. An IFN‐I signature was evident in DCs responding to the helminth Schistosoma mansoni or the allergen house dust mite ( HDM). Further, IFN‐I signaling was required for optimal DC phenotypic activation in response to helminth antigen (Ag), and efficient migration to, and localization with, T cells in the draining lymph node ( dLN). Importantly, DCs generated from Ifnar1 −/− mice were incapable of initiating Th2 responses in vivo. These data demonstrate for the first time that the influence of IFN‐I is not limited to antiviral or bacterial settings but also has a central role to play in DC initiation of Th2 responses.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

          MyD88, originally isolated as a myeloid differentiation primary response gene, is shown to act as an adaptor in interleukin-1 (IL-1) signaling by interacting with both the IL-1 receptor complex and IL-1 receptor-associated kinase (IRAK). Mice generated by gene targeting to lack MyD88 have defects in T cell proliferation as well as induction of acute phase proteins and cytokines in response to IL-1. Increases in interferon-gamma production and natural killer cell activity in response to IL-18 are abrogated. In vivo Th1 response is also impaired. Furthermore, IL-18-induced activation of NF-kappaB and c-Jun N-terminal kinase (JNK) is blocked in MyD88-/- Th1-developing cells. Taken together, these results demonstrate that MyD88 is a critical component in the signaling cascade that is mediated by IL-1 receptor as well as IL-18 receptor.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            IFNalpha activates dormant haematopoietic stem cells in vivo.

            Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

              We describe the generation of ovalbumin (OVA)-specific, MHC class II-restricted alpha beta T cell receptor (TCR) transgenic mice. Initial attempts at generating these transgenic mice utilized heterologous regulatory elements to drive the expression of cDNA genes encoding the separate alpha- and beta-chains of the TCR. Unexpectedly, T cells bearing the transgenic alpha beta TCR failed to emerge from the thymus in these mice, although the transgenes did modify endogenous TCR expression. However, subsequent modification of the approach which enabled expression of the TCR beta-chain under the control of its natural regulatory elements generated mice whose peripheral T cells expressed the transgenic TCR and were capable of antigen-dependent proliferation. These results show that successful generation of MHC class II-restricted, OVA-specific alpha beta TCR transgenic mice was dependent upon combining cDNA- and genomic DNA-based constructs for expression of the respective alpha- and beta-chains of the TCR.
                Bookmark

                Author and article information

                Contributors
                andrew.macdonald@manchester.ac.uk
                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                17 July 2017
                15 August 2017
                17 July 2017
                : 36
                : 16 ( doiID: 10.1002/embj.v36.16 )
                : 2404-2418
                Affiliations
                [ 1 ] Manchester Collaborative Centre for Inflammation Research University of Manchester Manchester UK
                [ 2 ] Institute of Immunology and Infection Research Centre for Immunity, Infection and Evolution University of Edinburgh Edinburgh UK
                [ 3 ] Malaghan Institute of Medical Research Wellington New Zealand
                [ 4 ] Fundamental and Applied Research in Animals and Health, Immunology‐Vaccinology Faculty of Veterinary Medicine University of Liege Liege Belgium
                [ 5 ] Plant Sciences Department Laboratory of Nematology Wageningen University and Research Centre Wageningen The Netherlands
                [ 6 ] Respiratory Infection Section National Heart and Lung Institute Imperial College London London UK
                [ 7 ]Present address: Baker Institute for Animal Health Cornell University College of Veterinary Medicine Ithaca NY USA
                [ 8 ]Present address: Biomedicine Discovery Institute Department of Biochemistry and Molecular Biology Monash University Clayton Vic. Australia
                Author notes
                [*] [* ]Corresponding author. Tel: +44 161 275 1504; E‐mail: andrew.macdonald@ 123456manchester.ac.uk
                [†]

                These authors contributed equally to this work

                Author information
                http://orcid.org/0000-0002-1903-7570
                http://orcid.org/0000-0003-0426-6562
                http://orcid.org/0000-0001-5835-8230
                Article
                EMBJ201695345
                10.15252/embj.201695345
                5556270
                28716804
                911d4f5c-1ec0-458e-a220-a67860b120ae
                © 2017 The Authors. Published under the terms of the CC BY 4.0 license

                This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 26 July 2016
                : 08 March 2017
                : 16 May 2017
                Page count
                Figures: 10, Tables: 0, Pages: 15, Words: 12041
                Funding
                Funded by: Wellcome Trust
                Award ID: WT086628MA
                Funded by: Belgian National Fund for Scientific Research Fonds De La Recherche Scientifique ‐ FNRS
                Award ID: CDRJ.0068.17
                Funded by: RCUK | Medical Research Council (MRC)
                Award ID: G0701437
                Award ID: G0800311
                Funded by: Manatu Hauora | Health Research Council of New Zealand (HRC)
                Award ID: HRC14/1003
                Funded by: National Health and Medical Research Council of Australia
                Award ID: GNT0567069
                Categories
                Article
                Articles
                Custom metadata
                2.0
                embj201695345
                15 August 2017
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.7 mode:remove_FC converted:15.08.2017

                Molecular biology
                dendritic cell,interferon,priming,th2,immunology,microbiology, virology & host pathogen interaction

                Comments

                Comment on this article